ABCG2
ABCG2 is an ATP-dependent efflux transporter of the ATP-binding cassette family that pumps a wide range of physiological compounds, dietary toxins and xenobiotics out of cells. It is also known as BCRP, MXR, ABCP and CD338, and carries the Junior (JR) blood group antigen. Browse Assay Genie's current range of ABCG2 research reagents below, or read on for the biology behind the target.
ABCG2 is a broad-specificity, ATP-dependent transporter that actively extrudes physiological compounds, dietary toxins and xenobiotics from cells. Its substrates include protoporphyrin IX, heme, sphingosine-1-phosphate, urate, the uremic toxin indoxyl sulfate, and sulfate-conjugated steroids such as estrone 3-sulfate and DHEAS. It also exports the vitamins riboflavin and biotin into milk, and itaconate from inflammatory macrophages, where it limits TFEB-dependent lysosome biogenesis. Through drug efflux it confers resistance to mitoxantrone, camptothecin, methotrexate, azidothymidine, and the anthracyclines daunorubicin and doxorubicin.
The protein operates at the apical membranes of polarised cells such as hepatocytes and intestinal epithelial cells, where it may contribute to the efflux of conjugated substrates into the intestinal lumen and to their enterohepatic recycling. It is also found at the mitochondrial membrane, where it exports protoporphyrin IX to the cytosol. It helps exclude xenobiotics from the brain and, in the placenta, limits drug penetration from maternal plasma into the fetus. It may also play a role in early stem cell self-renewal by blocking differentiation. The ABCG2 protein belongs to the ABC transporter superfamily and the ABCG family.
The ABCG2 gene encodes a member of the White subfamily of ABC transporters, which move molecules across extracellular and intracellular membranes. It was named breast cancer resistance protein for its role in multidrug resistance, and earlier names reflect its White subfamily and Junior blood group classification. Significant expression has been observed in the placenta, and multiple transcript variants encoding different isoforms have been reported. Mouse and rat orthologs are both designated Abcg2.
ABCG2 extrudes mitoxantrone, anthracyclines and other drugs, making it a central protein for studying how cells resist chemotherapy.
Its apical efflux in intestine, liver, brain and placenta shapes drug absorption, distribution and exclusion from the brain and fetus.
ABCG2 exports urate in renal and extrarenal excretion and clears indoxyl sulfate and sulfated steroids, linking it to metabolite handling.
ABCG2 may block differentiation in early stem cells and exports itaconate in inflammatory macrophages, influencing innate antibacterial responses.
ABCG2 is an ATP-dependent transporter that exports many compounds from cells, including xenobiotics, urate, heme, protoporphyrin IX, conjugated steroids and certain vitamins. Through drug efflux it confers resistance to agents such as mitoxantrone and anthracyclines, and it helps exclude xenobiotics from the brain and fetus.
ABCG2 is also called BCRP (breast cancer resistance protein), MXR, ABCP, CD338 and EST157481. Older names describe it as ATP-binding cassette, sub-family G (WHITE), member 2, and as the Junior blood group antigen. Multiple transcript variants encoding different isoforms have been described.
Yes. Mouse and rat each have an ortholog named Abcg2, so the transporter can be studied in rodent models. Check the datasheet of any product for its validated reactivity.
Other ABC subfamily G transporters and related efflux proteins with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9UNQ0; product specifications from Assay Genie datasheets.